Crescent Biopharma, Inc. Revenue

Revenue Gross Profit Operating Income EBITDA Net Income EPS Shares Outstanding

No data available.

Crescent Biopharma, Inc. (GLYC) — Frequently Asked Questions

Crescent Biopharma, Inc. (GLYC) is a publicly traded US company. Explore GLYC's stock price, financial statements, earnings history, margins and key ratios below.

What is the GLYC stock price?

GLYC trades at $17.98 (+5.73% on the day).